Psychedelics May Reduce Fear of Death, Echoing Near-Death Experiences, Study Finds ⋆ The Costa Rica News

A growing body of research is shedding light on the profound psychological effects of psychedelics, with new findings suggesting these substances may significantly reduce fear of death—producing effects similar to those reported by individuals who have had near-death experiences (NDEs).

A large-scale survey conducted by researchers at Johns Hopkins Medicine compared psychedelic experiences with non-drug-related near-death experiences and found striking similarities in how both groups perceive death afterward. The study, published in PLOS ONE on August 24, 2022, analyzed responses from more than 3,000 adults.

A Shared Shift in Perspective

Participants across both groups reported a notable reduction in their fear of death and dying following their experiences. Beyond that, many described these moments as deeply meaningful, often ranking them among the most spiritually significant events of their lives.

Roughly 90% of respondents in both categories said their fear of death had decreased. Additionally, a large majority—85% in the near-death group and 75% in the psychedelic group—considered the experience to be among the top five most meaningful in their lifetime.

These experiences also appeared to have lasting psychological benefits. Participants reported enduring improvements in overall well-being, a stronger sense of life purpose, and deeper personal insight. Are The Future Retreats or Therapies with Psychedelics?

Insights from Psychedelic Research

The findings align with previous clinical trials, particularly those involving psilocybin, the active compound in “magic mushrooms.” According to research published by the National Center for Biotechnology Information (NCBI), psilocybin-assisted therapy has shown promising results in reducing anxiety and depression in patients facing life-threatening illnesses.

In one landmark study led by Johns Hopkins researchers, cancer patients experiencing anxiety and depression were given a controlled dose of psilocybin alongside psychotherapy. The results were significant: participants reported increased acceptance of death and reduced anxiety, with effects lasting well beyond the treatment period.

Inside the Study

The survey analyzed data from 3,192 participants collected between December 2015 and April 2018. Of these:

• 933 individuals reported non-drug-related near-death experiences
• The remaining participants described psychedelic experiences involving:
  • LSD (904)
  • Psilocybin (766)
  • Ayahuasca (282)
  • DMT (307)

Demographically, the sample was predominantly white (85%) and largely based in the United States. The psychedelic group tended to be younger (average age 32) and more likely to be male compared to those who reported near-death experiences.

Key Differences Between Experiences

While the psychological outcomes were similar, the nature of the experiences differed:

• Individuals in the near-death group were far more likely to report being in life-threatening situations (47%), medically unconscious (36%), or even clinically dead (21%).
• In contrast, such conditions were rare in the psychedelic group.
• Near-death experiences were also typically shorter, with 40% lasting five minutes or less, compared to just 7% of psychedelic experiences.

For more scientific context on near-death experiences, you can explore research from the U.S. National Library of Medicine.

Looking Ahead: Therapeutic Potential

Researchers emphasize that more studies are needed to fully understand how psychedelics might be used in clinical settings, particularly for individuals struggling with existential distress, terminal illness, or anxiety related to death. Confirmed by Yale: Consuming Psychedelics Improves Mood

Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) are already advancing research into the therapeutic use of psychedelics, helping to shape future mental health treatments.

Still, the parallels between psychedelic journeys and near-death experiences open new avenues for exploring consciousness, mental health, and the human relationship with mortality.

As interest in psychedelic-assisted therapy continues to grow globally—including in progressive regions like Costa Rica—these findings may play a role in shaping future approaches to mental health and end-of-life care.

– Advertisement –